Changes in cholinesterase activities after daunorubicin administration to rabbits

Human & Experimental Toxicology

Volumn 15, Issue 10, 1996, Pages 834-838

  Gersl V ^a   Bajgar, J ^a   Krs, O ^b   Hrdina, R ^c   Palicka V ^d   Mazurova Y ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b DEPARTMENT OF TOXICOLOGY   (Czech Republic)

^c Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^d UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

cholinesterases; daunorubicin; heart; plasma; rabbit

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; DAUNORUBICIN;

ANIMAL EXPERIMENT; ARTICLE; CARDIOMYOPATHY; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HEART VENTRICLE SEPTUM; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RABBIT;

ACETYLCHOLINESTERASE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BODY WEIGHT; BUTYRYLCHOLINESTERASE; CARDIOMYOPATHIES; DAUNORUBICIN; HEART VENTRICLES; LIVER; MALE; MYOCARDIUM; RABBITS; TISSUE PRESERVATION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0029842970     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719601501007     Document Type: Article

References (29)

1. Cini Neri G. et al. Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat. Oncology 1991; 48: 327 - 33.
2. Geršl V., Hrdina R. Noninvasive polygraphic cardiac changes in daunorubicin - induced cardiomyopathy in rabbits. Sbornik vedeckych Praci LF UK Hradec Králové 1994; 37: 49-55.
3. Geršl V. et al. Changes of some biochemical and hematological parameters following administration of daunorubicin to rabbits. Sborník vedeckych Prací LF UK Hradec Králové 1995; 38: 79-84.
4. Slavíková J., Vlk J., Hlavicková V. Acetylcholinesterase and butyrylcholinesterase activity in the atria of the heart of adult albino rats. Physiologia Bohemoslovaca 1982; 31: 407-14.
5. Silver A. The Biology of Cholinesterases. Frontiers in Biology, Vol. 36, North Holland Publ. Co: Amsterdam - Oxford. 1974.
6. Czarnecki CM Animal models of drug-induced cardiomyopathy. Comparative Biochemistry and Physiology 1984; 79 C/1: 9 - 14.
7. Weissler AM, Schoenfeld CD Effect of digitalis on systolic time intervals in heart failure. American Journal of Medical Sciences 1970; 259: 4-20.
8. Ellman GL, Courtney DK, Andres V., Featherstone RM A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 1961; 7: 88-95.
9. Jbilo O., L'Hermite Y., Talesa V., Toutant JP, Chatonnet A. Acetylcholinesterase and butyrylcholinesterase expression in adult rabbit tissues and during development. European Journal of Biochemistry 1994; 225: 115-24.
10. Wicki A. Monitoring of acetylcholinesterase and butyrylcholinesterase activity in human whole blood. Proceeding of the CB Medical Symposium, 5 - 8 December 1994. Spiez, Switzerland 1994.
11. Bajgar J. Intoxication with organophosphorus cholinesterase inhibitors: effect, diagnosis and treatment (in Czech) Novinky v medicine c. 34, Praha: Avicenum - Zdravotnické nakladatelstvi 1985.
12. Brown SS, et al. The plasma cholinesterases: a new perspectives. Advances in Clinical Chemistry 1981; 22: 1-123.
13. Bajgar J. The influence of inhibitors and other factors on cholinesterases. Sborník vedeckych Prací LF UK Hradec Králové 1991; 34: 3 - 77.
14. Harvey AL The pharmacology of galanthamine and its analogues. Pharmacology and Therapeutics 1995; 68: 113 - 28.
15. Bajgar J. Cholinesterases and their clinical significance (in Czech). Praha: Státní pedagogické nakladatelství 1989.
16. Sazuka Y., Tanizava H., Takino Y. Effect of adriamycin on the activities of superoxide dismutase, glutathione peroxidase and catalase in tissues of mice. Japanese Journal of Cancer Research 1989; 80: 89 - 94.
17. Thayer WS Decreased cardiac lipoprotein lipase activity in rats treated chronically with adriamycin. Life Sciences 1985; 36: 635-41.
18. Papoian T., Lewis W. Anthracyclines selectively decrease alpha cardiac actin mRNA abundance in the rat heart. American Journal of Pathology 1992; 141: 1187 - 95.
19. Ito H. et al. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proceedings of National Academy of Sciences USA 1990; 87: 4275-9.
20. Odom AL, Hatwig CA, Stanley JS, Benson AM Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine. Biochemical Pharmacology 1992; 43: 831-6.
21. Miwa N., Kanaide H., Meno H., Nakamura M. Adriamycim and altered membrane functions in rat hearts. British Journal of Experimental Pathology 1986; 67: 747-55.
22. Monti E., Paracchini L., Perletti G., Piccinini F. Protective effects of spin - trapping agents on adriamycin - induced cardiotoxicity in isolated rat atria. Free Radical Research Communications 1991; 14: 41-5.
23. Soreq H., Gnatt A., Loewenstein Y., Neville LF Excavation into the active site-gorge of cholinesterase. Trends in Biochemical Sciences 1992; 17: 353-8.
24. Patocka J., Bajgar J., Bielavsky J., Fusek J. Kinetics of inhibition of cholinesterase by 1,2,3,4-tetrahydro-9-aminoacridine. Collection of Czechoslovak Chemical Communications 1976; 41: 816 - 24.
25. Puu G., Koch M. Comparison of kinetic parameters for acetylthiocholine, soman, ketamine and fasciculin towards acetylcholinesterase in liposomes and in solution. Biochemical Pharmacology, 1990; 40: 2209-14.
26. Kutty KM Biological function of cholinesterase. Clinical Biochemistry 1980; 13: 239-43.
27. Kassa J., Bajgar J. Comparison of the efficacy of HI-6 and obidoxime against cyclohexyl methylphosphonofluoridate (GF) in rats. Human and Experimental Toxicology 1995; 14: 923 - 8.
28. Traina ME, Serpietri LA Changes in the levels and form of plasma cholinesterase during chronic diisopropylphosphorofluoridate intoxication. Biochemical Pharmacology 1984; 33: 645-53.
29. Acker SABE van et al. Doxorubicin-Induced Chronic Cardiotoxicity Measured in Freely Moving Mice. In: Reduction of Anticancer Drug Toxicity. Basel: Karger 1995.